1. Home
  2. MCW vs ARDX Comparison

MCW vs ARDX Comparison

Compare MCW & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mister Car Wash Inc.

MCW

Mister Car Wash Inc.

HOLD

Current Price

$6.15

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$7.30

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCW
ARDX
Founded
1996
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
MCW
ARDX
Price
$6.15
$7.30
Analyst Decision
Buy
Strong Buy
Analyst Count
11
10
Target Price
$7.59
$12.95
AVG Volume (30 Days)
1.0M
4.5M
Earning Date
02-18-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
22.84
N/A
EPS
0.27
N/A
Revenue
$1,041,660,000.00
$398,234,000.00
Revenue This Year
$6.86
$22.44
Revenue Next Year
$6.96
$34.00
P/E Ratio
$22.79
N/A
Revenue Growth
6.98
58.12
52 Week Low
$4.61
$3.21
52 Week High
$8.60
$8.40

Technical Indicators

Market Signals
Indicator
MCW
ARDX
Relative Strength Index (RSI) 62.31 51.35
Support Level $5.33 $6.92
Resistance Level $6.24 $8.02
Average True Range (ATR) 0.21 0.36
MACD 0.05 -0.12
Stochastic Oscillator 89.06 23.31

Price Performance

Historical Comparison
MCW
ARDX

About MCW Mister Car Wash Inc.

Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: